A detailed history of Barr E S & CO transactions in Pfizer Inc stock. As of the latest transaction made, Barr E S & CO holds 8,768 shares of PFE stock, worth $230,072. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,768
Previous 8,908 1.57%
Holding current value
$230,072
Previous $247,000 0.81%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $3,536 - $4,144
-140 Reduced 1.57%
8,768 $245,000
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $24,466 - $28,094
-945 Reduced 9.59%
8,908 $247,000
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $24,692 - $32,073
945 Added 10.61%
9,853 $283,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $3,209 - $3,751
-100 Reduced 1.11%
8,908 $295,000
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $59,085 - $76,920
-1,500 Reduced 14.27%
9,008 $367,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $22,142 - $27,030
-506 Reduced 4.59%
10,508 $460,000
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $155,503 - $184,378
-3,342 Reduced 23.28%
11,014 $577,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $45,750 - $56,690
-1,000 Reduced 6.51%
14,356 $743,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $2,355 - $3,491
-57 Reduced 0.37%
15,356 $907,000
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $2,237 - $2,873
57 Added 0.37%
15,413 $663,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $109,094 - $123,585
3,038 Added 24.66%
15,356 $601,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $2,511 - $2,832
-75 Reduced 0.61%
12,318 $446,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $93,716 - $119,168
2,800 Added 29.19%
12,393 $456,000
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $9,874 - $11,584
-311 Reduced 3.14%
9,593 $352,000
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $36,144 - $43,848
-1,200 Reduced 10.81%
9,904 $324,000
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $57,519 - $82,183
-2,128 Reduced 16.08%
11,104 $362,000
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $13,238 - $14,864
-358 Reduced 2.63%
13,232 $573,000
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $51,450 - $56,526
-1,372 Reduced 9.17%
13,590 $577,000
Q3 2018

Nov 07, 2018

BUY
$34.47 - $41.81 $1,103 - $1,337
32 Added 0.21%
14,962 $659,000
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $9,924 - $11,513
311 Added 2.13%
14,930 $530,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $2,328 - $2,470
70 Added 0.48%
14,619 $530,000
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $451,019 - $496,848
14,549
14,549 $519,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Barr E S & CO Portfolio

Follow Barr E S & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barr E S & CO, based on Form 13F filings with the SEC.

News

Stay updated on Barr E S & CO with notifications on news.